This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as a Hybrid Event from September 20-30, 2021
Live In-Person Experience Delivered September 20-23Boston Convention and Exhibition Center

Jorge Santiago-Ortiz, Ph.D.
Director, Process Development at BioCentriq, USA


Dr. Jorge Santiago-Ortiz is a chemical engineer with a background in bioprocess engineering, molecular biology, and biochemistry and a focus in gene therapy and process development. Jorge completed his Bachelor’s Degree in Chemical Engineering with a Biotechnology Certificate in 2010 at the University of Puerto Rico, Mayagüez. In 2016, Jorge completed a Ph.D. in Chemical and Biomolecular Engineering with a Minor in Molecular and Cell Biology at the University of California, Berkeley. Working in Dr. David Schaffer’s laboratory, his Ph.D. dissertation work focused on the engineering of lentiviral and adeno-associated virus (AAV) vectors for gene therapy applications using in vitro and in vivo directed evolution. Following the completion of his Ph.D., Jorge transitioned to an industry role at BioConsortia Inc. (Davis, CA), where he led the fermentation and scale-up of beneficial plant-associated microbes for enhanced crop yields and improved plant health. In 2020, Jorge joined BioCentriq (Newark, NJ) as its Director of Process Development, where he oversees upstream and downstream process development for gene and cell therapy products and manages gene therapy research and development projects.

Agenda Sessions

  • ROOM 210C: Chairperson’s Opening Remarks:

  • ROOM 210A: Chairperson's Opening Remarks